Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

Obeso, J.A., Stamelou, M., Goetz, C.G., Poewe, W., Lang, A.E., Weintraub, D., Burn, D., Halliday, G.M., Bezard, E., Przedborski, S., Lehericy, S., Brooks, D.J., Rothwell, J.C., Hallett, M., DeLong, M.R., Marras, C., Tanner, C.M., Ross, G.W., Langston, J.W., Klein, C., Bonifati, V., Jankovic, J., Lozano, A.M., Deuschl, G., Bergman, H., Tolosa, E., Rodriguez‐Violante, M., Fahn, S., Postuma, R.B., Berg, D., Marek, K., Standaert, D.G., Surmeier, D.J., Olanow, C.W., Kordower, J.H., Calabresi, P., Schapira, A.H.V., Stoessl, A.J.·2017·Movement Disorders
DOI 10.1002/mds.27115

Cited by (736)

Items 701–736 of 736

  1. SNCA Deletion Induced Aberrant Projection of Olfactory Sensory Neurons via NCK2-EphA4 Pathway
    Jing Ren, Chao Wu, Jingjing Yue, Mengxia Zeng, Mingqin Qu, Ning Chen, Ge Gao, Yuwen Jiang, Jing Liu, Baoyang Hu et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  2. Development of the Forman Parkinson’s Disease Symptom Checklist
    B. Akram, Ivan Suneel · 2022 · Journal of Professional & Applied Psychology
  3. CAV2.3 expression is upregulated in the substantia nigra pars compacta of humans with Parkinson's disease
    Parnaz Sharifi, Haesoo Bae, Djordje O. Gveric, Steve Gentleman, Peter J. Smith, Travis S. Tierney, Kambiz N. Alavian · 2022 · Brain Disorders
  4. A Computational Approach in Identification of Putative Risk Genes in Parkinsons Disease
    Bhargav Dave, Prasenjit Majumder, Shamayeeta Sarkar · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Neuropathology, Genetics and Biomarkers of Synucleinopathies
    Shunsuke Koga, Hiroaki Sekiya, N. Kondru, O. Ross, Dennis W. Dickson · 2021 · Research Square
  6. Gear up for therapeutic application of non-invasive brain stimulation in Parkinson’s disease
    Masako Kinoshita, Antonio Suppa · 2021 · Clinical Neurophysiology
  7. Parkinsonism
    Joseph J. Jankovic, Mark Hallett, Michael S. Okun, Cynthia Comella, Stanley Fahn, Jennifer G. Goldman · 2021 · Elsevier eBooks
  8. Estudo da neuropatia periférica em pacientes com doença de Parkinson: Revisão de literatura
    Antonia Viana, João Santos Pereira, Robson Teixeira Vital · 2021 · Research Society and Development
  9. Белок DJ-1 и его роль в развитии болезни Паркинсона: исследования на экспериментальных моделях
    О.А. Бунеева, Alexey E. Medvedev · 2021 · Biochemistry (Moscow)
  10. Causal Connection Between Serum Levodopa Metabolic Profile and Medication in Parkinson’s Disease
    Akiko Chukyo, Motoki Fujimaki, Naoko Kaga, Hikari Taka, Yuanzhe Li, Shin‐Ichi Ueno, Haruka Takeshige‐Amano, Manabu Funayama, Tomohiro Ishimaru, Kengo Miyamoto et al. · 2021 · Research Square
  11. Different RNA profiles in plasma derived small and large extracellular vesicles of Neurodegenerative diseases patients
    D. Sproviero, S. Gagliardi, S. Zucca, M. Arigoni, Marta Giannini, M. Garofalo, M. Olivero, M. Dell’Orco, O. Pansarasa, Stefano Bernuzzi et al. · 2020 · bioRxiv
  12. The cis-Regulatory Element of SNCA Intron 4 Modulates Susceptibility to Parkinson’s Disease in Han Chinese
    Shi-Guo Zhu, Hui Lu, M. Mao, Zhao-Feng Li, Lei Cui, Begench Ovlyakulov, Xiong Zhang, Jian-Hong Zhu · 2020 · Frontiers in Genetics
  13. Boophone Haemanthoides (Amaryllidaceae) and Its Bioactive Compounds Attenuate MPP+-Induced Toxicity in an in Vitro Parkinson’s Disease Model
    Abobaker S. Ibrakaw, Sylvester Ifeanyi Omoruyi, Okobi Eko Ekpo, Ahmed Abdullah Hussein · 2020 · Preprints.org
  14. Diagnóstico y abordaje de las alteraciones asociadas a la enfermedad de Parkinson en atención primaria
    M. Monje, R. Martínez-Fernández · 2020
  15. ROLE OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN TREATMENT OF COGNITIVE MANIFESTATIONS IN PARKINSON'S DISEASE
    Taha Allosh, Mahmoud Elbalkemy, Nevine M. El Nahas, Ali Shalash, Tamer Emara, Mohamed Elshiekh · 2020 · Ain Shams Medical Journal
  16. Psychiatric Discourse: Scientific Reductionism for the Autonomous Person
    Stephan Heckers · 2020 · Cambridge University Press eBooks
  17. Lifestyle Impact on Cognitive Decline and Neurodegeneration Overview groupview
    Alexander Victor Anand David, Subramani Parasuraman · 2020 · Free Radicals and Antioxidants
  18. Cerebral blood flow and cerebrovascular reactivity in Parkinson’s disease: relationship with severity of motor symptoms
    L. Pelizzari, M. M. Laganá, F. Rossetto, N. Bergsland, G. Baselli, M. Clerici, R. Nemni, M. Meloni, F. Baglio · 2019 · Veins and Lymphatics
  19. Editor's note: The origin of Parkinson's disease: The importance of environment and lifestyle
    J. Obeso · 2019 · Movement Disorders
  20. Opto-activation of cortical somatostatin interneurons alleviates parkinsonian symptoms
    Marie Vandecasteele, S. Valverde, Charlotte Piette, G. Gangarossa, Willy Derousseaux, Asier Aristieta Arbelaiz, J. Touboul, B. Degos, L. Venance · 2018 · bioRxiv
  21. Current Therapeutic Strategies of Parkinson's Disease
    K. Jeevaratnam · 2018
  22. Basal Ganglia Paths Support Acute vs. Learned Execution, Not Movement vs. Stopping
    Ari Rappoport · 2018 · Preprints.org
  23. Too good to be true
    Francisco Cardoso · 2018 · Arquivos de Neuro-Psiquiatria
  24. Neue Therapien am Horizont?
    Stephan Klebe · 2017 · DNP - Der Neurologe und Psychiater
  25. Automated Segmentation of the Brainstem Using Deep Learning U-Net Architectures Applied to Multiplanar Magnetic Resonance Images
    Gabriela Diógenes, Cristiano Miosso, Pedro Renato P. Brandão, Brenda Macedo, Marcelo Lobo, D. D. de Carvalho Bispo · 2026 · Journal of Biomedical Engineering and Biosciences
  26. Voice and speech in Parkinson's disease: Clinical characteristics of hypokinetic dysphonia
    Ivana Ilić-Savić, M. Petrović-Lazić, Snežana Babac · 2026 · Zdravstvena zastita
  27. Application of Transcranial Ultrasound in the Diagnosis and Treatment of Parkinson’s Disease
    Yuan-Wei Li · 2025 · Advances in Clinical Medicine
  28. Buprenorfina transdérmica, una alternativa en el tratamiento del dolor en pacientes con enfermedad de Parkinson Avanzada: Enfoque Paliativo.
    Zoila Trujillo de los Santos, Jesús Aarón García Sandoval, Francisco Paz Rodríguez, María Alejandra Sánchez Guzmán, Ma. Guadalupe Nava Galán · 2023 · Multidisciplinary Pain Journal
  29. Etiology and pathogenesis of Parkinson disease
    Joseph J. Jankovic, Mark Hallett, Michael S. Okun, Cynthia Comella, Stanley Fahn, Jennifer G. Goldman · 2021 · Elsevier eBooks
  30. Motor control
    Joseph J. Jankovic, Mark Hallett, Michael S. Okun, Cynthia Comella, Stanley Fahn, Jennifer G. Goldman · 2021 · Elsevier eBooks
  31. Dual Task Performance and Prioritization in Parkinson’s Disease and Healthy Elderly Individuals: Analysis of a Novel Assessment With Increasing Complexity
    J. Fineman · 2020
  32. The different syndromes in Parkinson's disease: an overview
    Nikolaos Giagkou, M. Stamelou · 2020
  33. Basal Ganglia
    Hans J. ten Donkelaar, Bart P.C. van de Warrenburg, Michèl A.A.P. Willemsen, Benno Küsters, Yoshio Hashizume, Akira Hori · 2020 · Springer eBooks
  34. Validating Gpr88 as a new therapeutic target in models of the neuropsychiatric symptoms of Parkinson's Disease
    Benjamin Galet · 2018 · theses.fr (ABES)
  35. Erythropoietin as a Modulator of Pathology in a Toxicant Mouse Model of Parkinson’s Disease
    Ashley Thompson · 2019 · Carleton University's Institutional Repository (MacOdrum Library, Carleton University)
  36. Sergančiųjų Parkinsono liga faktinės mitybos ir mitybos įpročių sąsaja su ligos motoriniais ir nemotoriniais simptomais
    Jevgenija Guk · 2026